Suppr超能文献

双嘧达莫通过PKA/PKG途径调节M1巨噬细胞极化减轻实验性牙周炎

Dipyridamole Attenuates Experimental Periodontitis by Regulating M1 Macrophage Polarization via PKA/PKG Pathways.

作者信息

Song Jiaying, Li Xingyi, Abuduwaili Kailibinuer, Sun Yue, Li Jiangbo, Chen Danying, Chen Zhuofan, Li Zhipeng, Huang Baoxin

机构信息

Hospital of Stomatology, Sun Yat-Sen University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.

出版信息

J Periodontal Res. 2025 Jul;60(7):710-722. doi: 10.1111/jre.13378. Epub 2025 Jan 12.

Abstract

AIM

Periodontitis is a chronic inflammatory disease initiated by dysbiosis of the local microbial community. As a non-specific phosphodiesterase inhibitor, dipyridamole features anti-oxidant and anti-inflammatory properties. This study aimed to investigate the effects of dipyridamole in an experimental rat model of periodontitis.

METHODS

Thirty rats were divided randomly into three groups (n = 10): non-ligature group (NL), ligature-induced periodontitis group (L), and ligature-induced periodontitis with dipyridamole administered group (L + D). All rats were euthanized on Day 14. Alveolar bone resorption was analyzed by microcomputed tomography. The mRNA levels of Il1b, Il6, tumor necrosis factor alpha (Tnfa), and inducible nitric oxide synthase (iNos) in gingival tissue were assessed by real-time quantitative polymerase chain reaction (qRT-PCR). Inflammation level, osteoclasts, and macrophages infiltration were analyzed histologically. RAW264.7 macrophages were stimulated with Porphyromonas gingivalis lipopolysaccharide (P.g. LPS) to induce M1 polarization. Different concentration of dipyridamole (0/2/10 μM) was added simultaneously. To explore the role of PKA/PKG pathways, RAW 264.7 macrophages were pretreated with 10 μM H-89 (PKA inhibitor) or 1 μM KT-5823 (PKG inhibitor), respectively. Expression of pro-inflammatory cytokines and M1 markers were detected by qRT-PCR, ELISA, and flow cytometry.

RESULTS

Dipyridamole administration reduced alveolar bone loss, protein levels of inflammatory cytokines, and osteoclastogenesis in rats with experimental periodontitis. It also showed a tendency to decrease mRNA levels of Il1b, Il6, and Tnfa but without significant differences in gingival tissues. Moreover, the infiltration of macrophage and M1 macrophage polarization in gingival tissue of periodontitis rats were inhibited by dipyridamole administration. In addition, dipyridamole could downregulate the gene expression of Il1b and Tnfa, as well as the protein level of TNF-α, CD86, and iNOS in RAW264.7 treated with P.g. LPS. When PKA/PKG pathways were blocked, the suppression of TNF-α, CD86, and iNOS was reversed significantly.

CONCLUSION

Dipyridamole alleviated experimental periodontitis in rat models by regulating M1 polarization via activation of PKA/PKG pathways and emerges as a hopeful remedy for periodontitis.

摘要

目的

牙周炎是一种由局部微生物群落失调引发的慢性炎症性疾病。双嘧达莫作为一种非特异性磷酸二酯酶抑制剂,具有抗氧化和抗炎特性。本研究旨在探讨双嘧达莫在实验性大鼠牙周炎模型中的作用。

方法

将30只大鼠随机分为三组(n = 10):非结扎组(NL)、结扎诱导牙周炎组(L)和结扎诱导牙周炎并给予双嘧达莫组(L + D)。所有大鼠在第14天安乐死。通过微型计算机断层扫描分析牙槽骨吸收情况。采用实时定量聚合酶链反应(qRT-PCR)评估牙龈组织中白细胞介素1β(Il1b)、白细胞介素6(Il6)、肿瘤坏死因子α(Tnfa)和诱导型一氧化氮合酶(iNos)的mRNA水平。组织学分析炎症水平、破骨细胞和巨噬细胞浸润情况。用牙龈卟啉单胞菌脂多糖(P.g. LPS)刺激RAW264.7巨噬细胞诱导M1极化,同时加入不同浓度的双嘧达莫(0/2/10 μM)。为探究蛋白激酶A(PKA)/蛋白激酶G(PKG)信号通路的作用,分别用10 μM H-89(PKA抑制剂)或1 μM KT-5823(PKG抑制剂)预处理RAW 264.7巨噬细胞。通过qRT-PCR、酶联免疫吸附测定(ELISA)和流式细胞术检测促炎细胞因子和M1标志物的表达。

结果

给予双嘧达莫可减少实验性牙周炎大鼠的牙槽骨丢失、炎症细胞因子蛋白水平和破骨细胞生成。它还显示出降低牙龈组织中Il1b、Il6和Tnfa mRNA水平的趋势,但差异无统计学意义。此外,给予双嘧达莫可抑制牙周炎大鼠牙龈组织中巨噬细胞浸润和M1巨噬细胞极化。另外,双嘧达莫可下调P.g. LPS处理的RAW264.7细胞中Il1b和Tnfa的基因表达以及肿瘤坏死因子-α(TNF-α)、CD86和诱导型一氧化氮合酶(iNOS)的蛋白水平。当PKA/PKG信号通路被阻断时,TNF-α、CD86和iNOS的抑制作用明显逆转。

结论

双嘧达莫通过激活PKA/PKG信号通路调节M1极化,从而减轻大鼠模型中的实验性牙周炎,有望成为牙周炎的一种治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验